These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 23573663)

  • 1. Facilitated PCI for ST segment elevation myocardial infarction.
    Young JJ
    J Invasive Cardiol; 2004 Sep; Suppl():4-9. PubMed ID: 23573663
    [No Abstract]   [Full Text] [Related]  

  • 2. ST-segment recovery and prognosis in patients with ST-elevation myocardial infarction reperfused by prehospital combination fibrinolysis, prehospital initiated facilitated percutaneous coronary intervention, or primary percutaneous coronary intervention.
    Thiele H; Scholz M; Engelmann L; Storch WH; Hartmann A; Dimmel G; Pfeiffer D; Schuler G;
    Am J Cardiol; 2006 Nov; 98(9):1132-9. PubMed ID: 17056313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coupling drug and catheter therapy for myocardial infarction.
    Lincoff AM
    JAMA; 2004 Feb; 291(8):1000-2. PubMed ID: 14982917
    [No Abstract]   [Full Text] [Related]  

  • 4. ST-segment resolution 60 minutes after combination treatment of abciximab with reteplase or reteplase alone for acute myocardial infarction (30-day mortality results from the resolution of ST-segment after reperfusion therapy substudy).
    Cura FA; Roffi M; Pasca N; Wolski KE; Lincoff AM; Topol EJ; Lauer MS;
    Am J Cardiol; 2004 Oct; 94(7):859-63. PubMed ID: 15464665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abciximab and early adjunctive percutaneous coronary intervention are associated with improved ST-segment resolution after thrombolysis: Observations from the TIMI 14 Trial.
    de Lemos JA; Gibson CM; Antman EM; Murphy SA; Morrow DA; Schuhwerk KC; Schweiger M; Coussement P; Van de Werf F; Braunwald E;
    Am Heart J; 2001 Apr; 141(4):592-8. PubMed ID: 11275925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefit of facilitated percutaneous coronary intervention in high-risk ST-segment elevation myocardial infarction patients presenting to nonpercutaneous coronary intervention hospitals.
    Herrmann HC; Lu J; Brodie BR; Armstrong PW; Montalescot G; Betriu A; Neuman FJ; Effron MB; Barnathan ES; Topol EJ; Ellis SG;
    JACC Cardiovasc Interv; 2009 Oct; 2(10):917-24. PubMed ID: 19850249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of acute ST-segment elevation myocardial infarction in diabetics treated with fibrinolytic or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: lessons from the GUSTO V trial.
    Gurm HS; Lincoff AM; Lee D; Tang WH; Jia G; Booth JE; Califf RM; Ohman EM; Van de Werf F; Armstrong PW; Guetta V; Wilcox R; Topol EJ;
    J Am Coll Cardiol; 2004 Feb; 43(4):542-8. PubMed ID: 14975461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early administration of reteplase plus abciximab vs abciximab alone in patients with acute myocardial infarction referred for percutaneous coronary intervention: a randomized controlled trial.
    Kastrati A; Mehilli J; Schlotterbeck K; Dotzer F; Dirschinger J; Schmitt C; Nekolla SG; Seyfarth M; Martinoff S; Markwardt C; Clermont G; Gerbig HW; Leiss J; Schwaiger M; Schömig A;
    JAMA; 2004 Feb; 291(8):947-54. PubMed ID: 14982910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facilitated percutaneous coronary intervention in patients with acute myocardial infarction transferred from remote hospitals.
    Dudek D; Zmudka K; Kaluza GL; Kuta M; Pieniazek P; Przewlocki T; Zorkun C; Legutko J; Gajos G; Bartuś S; Bryniarski L; Dziewierz A; Pasowicz M; Dubiel JS
    Am J Cardiol; 2003 Jan; 91(2):227-9. PubMed ID: 12521638
    [No Abstract]   [Full Text] [Related]  

  • 10. Revascularization techniques in acute myocardial infarction.
    Gorman RC; Gorman JH
    N Engl J Med; 2000 Dec; 343(24):1815. PubMed ID: 11185605
    [No Abstract]   [Full Text] [Related]  

  • 11. Angiographic and clinical characteristics associated with the development of Q-wave and non-Q-wave myocardial infarction in the thrombolysis in myocardial infarction (TIMI) 14 trial.
    Murphy SA; Dauterman K; de Lemos JA; Kermgard S; Antman EM; Braunwald E; Gibson CM;
    Am Heart J; 2003 Jul; 146(1):42-7. PubMed ID: 12851606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined Abciximab REteplase Stent Study in acute myocardial infarction (CARESS in AMI).
    Di Mario C; Bolognese L; Maillard L; Dudek D; Gambarati G; Manari A; Guiducci V; Patrizi G; Rusconi LC; Piovaccari G; Hibon AR; Belpomme V; Indolfi C; Olivari Z; Steffenino G; Zmudka K; Airoldi F; Panzarasa R; Flather M; Steg PG
    Am Heart J; 2004 Sep; 148(3):378-85. PubMed ID: 15389222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefical effects of reteplase in combination with abciximab: platelet/leukocyte interactions and coagulation system.
    Szabo S; Walter T; Etzel D; Ehlers R; Kazmaier S; Beyer ME; Hoffmeister HM
    Int J Clin Pharmacol Res; 2003; 23(2-3):37-40. PubMed ID: 15018016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention: design and rationale of the Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events (FINESSE) trial.
    Ellis SG; Armstrong P; Betriu A; Brodie B; Herrmann H; Montalescot G; Neumann FJ; Smith JJ; Topol E;
    Am Heart J; 2004 Apr; 147(4):E16. PubMed ID: 15077099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of ST-segment resolution with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy versus fibrinolytic alone (data from four clinical trials).
    Rebeiz AG; Johanson P; Green CL; Crater SW; Roe MT; Langer A; Giugliano RP; Lincoff AM; Newby LK; Harrington RA; Topol EJ; Califf RM; Wagner GS; Krucoff MW
    Am J Cardiol; 2005 Mar; 95(5):611-4. PubMed ID: 15721101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination pharmacotherapy with reduced-dose fibrinolytic and platelet GP IIb/IIIa inhibition.
    Bush HS
    J Emerg Med; 2003 Nov; 25(4):421-6. PubMed ID: 14654184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1-year survival in a randomized trial of facilitated reperfusion: results from the FINESSE (Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events) trial.
    Ellis SG; Tendera M; de Belder MA; van Boven AJ; Widimsky P; Andersen HR; Betriu A; Savonitto S; Adamus J; Peruga JZ; Hamankiewicz M; Pluta W; Oldroyd K; Ecollan P; Janssens L; Armstrong P; Brodie BR; Herrmann HC; Montalescot G; Neumann FJ; Effron MB; Barnathan ES; Topol EJ;
    JACC Cardiovasc Interv; 2009 Oct; 2(10):909-16. PubMed ID: 19850248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined assessment of thrombolysis in myocardial infarction flow grade, myocardial perfusion grade, and ST-segment resolution to evaluate epicardial and myocardial reperfusion.
    Giugliano RP; Sabatine MS; Gibson CM; Roe MT; Harrington RA; Murphy SA; Morrow DA; Antman EM; Braunwald E
    Am J Cardiol; 2004 Jun; 93(11):1362-7, A5-6. PubMed ID: 15165915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators.
    Schömig A; Kastrati A; Dirschinger J; Mehilli J; Schricke U; Pache J; Martinoff S; Neumann FJ; Schwaiger M
    N Engl J Med; 2000 Aug; 343(6):385-91. PubMed ID: 10933737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facilitated percutaneous intervention following combination therapy with reteplase and abciximab for acute myocardial infarction.
    Weinstock BS
    J Invasive Cardiol; 2002 Feb; 14(2):100-4; quiz 104-5. PubMed ID: 11818648
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.